C-4″ position substituted macrolide derivative

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9139609
APP PUB NO 20140046043A1
SERIAL NO

14000556

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A macrolide compound represented by the formula (I) effective against erythromycin resistant bacteria (for example, resistant pneumococci, streptococci and mycoplasmas).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAISHO PHARMACEUTICAL CO LTDTOKYO 171
MEIJI SEIKA PHARMA CO LTDTOKYO 104-8002

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hayashi, Masato Saitama, JP 101 889
Kanemoto, Kenichi Chiba, JP 7 35
Kashimura, Masato Saitama, JP 24 301
Kumura, Kou Tokyo, JP 5 42
Kurosaka, Jun Saitama, JP 4 30
Miura, Tomoaki Kanagawa, JP 13 54
Ogita, Haruhisa Saitama, JP 12 991
Sasamoto, Naoki Saitama, JP 5 30
Shitara, Eiki Kanagawa, JP 19 95
Sugimoto, Tomohiro Saitama, JP 58 573
Tamura, Keiji Tokyo, JP 15 69
Ushiki, Yasunobu Saitama, JP 5 12
Yamamoto, Kanako Saitama, JP 7 42
Yoshida, Satoshi Tokyo, JP 330 2967

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 22, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00